Search

Karyopharm Therapeutics Inc

Lezárt

SzektorEgészségügy

1.75 -2.78

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

1.65

Maximum

1.81

Fő mutatók

By Trading Economics

Bevétel

-45M

-67M

Értékesítés

-1.6M

33M

Egy részvényre jutó nyereség

-2.32

Profit margin

-200.476

Munkavállalók

228

EBITDA

-44M

-54M

Ajánlások

By TipRanks

Ajánlások

Vétel

12 hónapos előrejelzés

+259.12% upside

Osztalékok

By Acuity

Következő eredményjelentés

2026. nov. 2.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-2.2M

42M

Előző nyitás

4.53

Előző zárás

1.75

Hangulat hírek alapján

By Acuity

36%

64%

86 / 339 Rangsor szerint Healthcare

Karyopharm Therapeutics Inc Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. szept. 23. 20:07 UTC

Karyopharm Therapeutics Inc shares fell sharply amid broader market pressure, continuing a decline since Tuesday's close, despite a slight recovery earlier in the session.

2026. szept. 22. 20:07 UTC

Karyopharm Therapeutics Inc shares fell, reflecting broader market declines, after an earlier rebound from a session low. The stock remains above its 20-day moving average.

2026. szept. 21. 20:01 UTC

Karyopharm Therapeutics Inc is rising, trading above its 20-day moving average and extending a trend of four consecutive sessions closing higher.

2026. szept. 18. 20:02 UTC

Karyopharm Therapeutics Inc is sharply higher in Friday's trading session, despite currently trading lower and diverging from recent upward momentum.

2026. szept. 17. 20:07 UTC

Karyopharm Therapeutics Inc is gaining during Thursday's trading, advancing significantly since Wednesday's close and peaking near the session's end.

2026. szept. 16. 19:43 UTC

Karyopharm Therapeutics Inc is trading sharply higher, reaching a peak this morning before slightly retracing, but remains below its 20-day moving average.

2026. szept. 15. 19:53 UTC

Karyopharm Therapeutics Inc shares are lower amid broader market declines and investor concerns over anticipated Federal Reserve rate hikes and geopolitical tensions.

2026. szept. 11. 20:01 UTC

News
Macro Event

Karyopharm Therapeutics has entered a Forbearance Agreement, trading lower as it faces a $15.8 million principal payment due and $20 million in fees.

2026. szept. 10. 20:07 UTC

Karyopharm Therapeutics is lower today, continuing a broader trend of weakness and remaining below its 20-day moving average. No specific news was identified.

2026. szept. 8. 20:07 UTC

News

Karyopharm Therapeutics shares are lower after downgrades from Robert W. Baird and HC Wainwright, with a target price set at $3.00.

2026. szept. 2. 20:08 UTC

Karyopharm Therapeutics Inc shares are lower today, having reached a session low earlier. The stock remains near the lower end of its one-month range.

2026. szept. 1. 20:01 UTC

Event

Karyopharm Therapeutics submitted a supplemental New Drug Application for XPOVIO, but shares are trading lower amid broader market concerns about rising oil prices and interest rates.

2026. aug. 31. 20:02 UTC

Event
News
Social Media

Karyopharm Therapeutics submitted a supplemental New Drug Application for XPOVIO, seeking Accelerated Approval for myelofibrosis treatment. Shares are gaining during Monday's session.

2026. aug. 28. 20:08 UTC

Karyopharm Therapeutics Inc shares declined during Friday's session amid rising U.S. Treasury yields, reflecting broader market trends. The stock finished near its one-month low.

2026. aug. 25. 20:07 UTC

Karyopharm Therapeutics Inc shares are higher during Tuesday's session, reaching a peak earlier in the day. The stock remains below its 20-day moving average.

2026. aug. 24. 19:16 UTC

Karyopharm Therapeutics Inc shares are lower today, reaching a session low amid ongoing market weakness and no specific news to explain the decline.

2026. aug. 21. 23:51 UTC

Karyopharm Therapeutics Inc shares are lower in after-market hours, following a brief uptick earlier. No specific news was identified to explain the decline.

2026. aug. 20. 20:02 UTC

Karyopharm Therapeutics is declining sharply amid a significant downturn in the Biotechnology sub-sector, nearing the lower end of its one-month trading range.

2026. aug. 18. 20:03 UTC

Karyopharm Therapeutics Inc is trading higher today, continuing its upward trend since Monday's close. The stock remains below its 20-day moving average.

2026. aug. 17. 23:46 UTC

Karyopharm Therapeutics shares are higher in after-market hours, following volatility earlier. Broader market pressures include geopolitical tensions and rising crude oil prices.

2026. aug. 14. 23:51 UTC

Karyopharm Therapeutics shares are higher in after-market trading, despite no specific news. Broader market sentiment reflects concerns from a decline in U.S. retail sales.

2026. aug. 13. 23:11 UTC

Karyopharm Therapeutics Inc shares are rising in after-market trading, showing a modest upward trend since Thursday's close despite recent significant declines.

2026. aug. 12. 19:56 UTC

Karyopharm Therapeutics Inc shares are lower today, retracing from an early high amid broader market conditions and geopolitical tensions. No specific news was identified.

2026. aug. 11. 20:01 UTC

Karyopharm Therapeutics Inc is trading higher today, having reached a peak earlier in the session. The stock remains below its 20-day moving average.

2026. aug. 10. 20:06 UTC

Karyopharm Therapeutics Inc shares are lower today, reversing an early gain and reaching a mid-morning low, with no specific news identified for the decline.

2026. aug. 7. 23:31 UTC

Karyopharm Therapeutics shares are lower in after-market hours, following a decline earlier despite gains in major tech stocks. No specific news was identified.

2026. aug. 6. 23:21 UTC

Karyopharm Therapeutics Inc shares are lower in after-market hours. The asset is trading below its 20-day moving average and near the lower end of its one-month range.

2026. aug. 5. 23:01 UTC

Karyopharm Therapeutics shares are lower in after-market hours, continuing a three-session decline amid broader market weakness from disappointing U.S. employment data.

2026. aug. 4. 23:46 UTC

Karyopharm Therapeutics shares are higher in after-market trading, though no specific news explains the movement. Broader market optimism may be influencing risk assets.

2026. aug. 3. 23:41 UTC

News

Karyopharm Therapeutics shares are lower in after-market hours following the grant of restricted stock units to a new employee, raising potential dilution concerns.

Társak összehasonlítása

Árváltozás

Karyopharm Therapeutics Inc Előrejelzés

Célár

By TipRanks

259.12% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 6.536 USD  259.12%

Magas 11 USD

Alacsony 3 USD

6 Wall Street elemző 12 hónapos célárain alapulva a(z)Karyopharm Therapeutics Inc termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

6 ratings

4

Vétel

2

Tartás

0

Eladás

Hangulat

By Acuity

86 / 339 Rangsor szerint Egészségügy

Hangulat hírek alapján

Bullish bizonyíték

Volatilitás

Átlag alatti

Hírmennyiség (RCV)

Átlag feletti

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$